| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |